Phys Vivas · cardiovascular
Adult Congenital Heart Disease — Viva Defence
DCE viva defence for Adult Congenital Heart Disease.
On this page & tools
Target exams
Adult Congenital Heart Disease Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Adult Congenital Heart Disease. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Wolf SEM, Jiang H, Boyd RR, Overman RE Jr, et al. Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery World J Pediatr Congenit Heart Surg, 2026.PMID 42454881
- [2]Habibi H, Brida M, Gatzoulis MA Beyond survival: empowering adults with congenital heart disease through communication and co-designed education J Thorac Dis, 2026.PMID 42444962
- [3]Veldtman H, Nizam MA, Brock S, Kandi S, et al. A bibliometric analysis of medication studies in congenital heart disease Int J Cardiol Congenit Heart Dis, 2026.PMID 42438601
- [4]Batra AS, Hamidy M, McCanta A, Sell L, et al. Practice Variation in Infective Endocarditis Prophylaxis for Pediatric and Congenital Heart Disease Patients with Cardiac Implantable Electronic Devices: An International Survey Pediatr Cardiol, 2026.PMID 42423984
- [5]Das BB Advances and unmet needs in pharmacologic therapy for pediatric heart failure: Insights from the 2025 International Society for Heart and Lung Transplantation Guidelines Ann Pediatr Cardiol, 2026.PMID 42404509
- [6]Kholeif Z, Ellabbad M, Miranda WR, Connolly HM, et al. Clinical benefit of optimization of heart failure therapy after heart failure hospitalization in adults with CHD Int J Cardiol Congenit Heart Dis, 2026.PMID 42376565
- [7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
- [8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005